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Abstract
Introduction:	Microcytic	anemia	is	a type	of	anemia	with	smaller	than	normal	red	blood	cells.	Iron	deficiency	anemia	and	thalas-
semia	are	some	of	the	major	causes.	The	aim	of	the	study	was	to	compare	the	pulmonary	function	of	the	subjects	with	microcytic	
anemia	to	the	respective	results	of	the	normal	population.	
Material and methods:	This	was	a cross-sectional	study	in	Bandar	Abbas,	Iran,	conducted	on	the	patients	attending	yearly	oc-
cupational	health	checkups.	Complete	blood	cell	count	and	a standard	spirogram	were	attained	from	each	consenting	participant	
and	occupational	histories	of	exposure	to	dust,	fumes,	solvents,	and	noxious	gases	were	obtained.
Results:	At	last,	2,199	subjects	were	included	in	the	analysis,	of	which	335	cases	had	microcytic	anemia.	There	was	a significant	
association	between	having	microcytic	anemia	and	forced	vital	capacity	(FVC)	reduction,	and	to	a lesser	degree,	the	reduction	
of	forced	expiratory	volume	in	the	first	second	(FEV1).	These	parameters	were	also	significantly	increased	together	with	the	rise	
of	mean	corpuscular	volume	(MCV)	in	the	sample	population.	
Conclusion:	 It	can	be	concluded	that	having	microcytic	anemia	may	reduce	some	spirometric	parameters.	Even	though	these	
changes	are	small,	adjusting	for	the	reduced	values	can	help	prevent	an	overestimation	of	lung	disorders,	mostly	in	borderline	cases.
Key words:	thalassemia,	anemia,	iron	deficiency,	respiratory	function	tests,	spirometry
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Introduction
Microcytic anemia is a type of anemia with 
smaller than normal red blood cells (RBCs). It 
is widely categorized as iron deficiency anemia 
(deficiency in iron delivery to the heme group), 
thalassemia (deficiency of globin production), 
anemia of chronic disease (reduced iron delivery 
to the heme group), and anemia because of other 
minor causes [1]. Hemoglobinopathies (including 
thalassemia) constitute one of the most common 
inherited diseases that are transmitted by single 
genes [2]. Iron deficiency anemia is the most 
common type of the condition [1]. 
Each year, 60,000 new babies with severe 
thalassemia are born, mostly in the tropical and 
subtropical regions of the world. Unfortunately, 
there is no definitive treatment for thalassemia 
and the care is mostly supportive [3]. Milder ca-
ses of thalassemia are more common and usually 
symptom-free. Mild anemia is the only finding 
in these cases [4]. Basing on the genes involved, 
thalassemia is divided into alpha and beta thalas-
semia. Beta-thalassemia is defined by abnormal 
synthesis of the beta chains of the hemoglobin 
(due to mutation or deletion of the beta-globin 
gene). The disorder range from asymptomatic 
and mild to moderate and severe anemia [5]. Al-
pha-thalassaemia is also an inherited condition 
(affecting alpha-globin genes) that causes micro-
cytic anemia. It is a predominant illness in the 
Middle East [6].
Iron deficiency anemia is a  disease with 
diverse causes. About 50% of the anemia cases 
worldwide are iron deficiency anemia. The cau-
ses of the disorder can be the following: reduced 
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intakes of iron, decreased absorption of it, or even 
blood loss. The gold standard for the diagnosis of 
the disorder is bone marrow aspiration or biopsy, 
which is invasive and is replaced by less invasive 
methods [7]. Mean corpuscular volume (MCV) 
less than 80 fL has been used as the screening 
method for thalassemia [8]. It is also reduced in 
many cases of iron deficiency anemia.
Impairment of lung function has been shown 
to be associated with major thalassemia. Both 
restrictive and obstructive patterns have been 
observed. A higher prevalence of restrictive lung 
function has been found in one study. There has 
not been any association between lung function 
and serum ferritin in the study [9, 10]. Impairment 
of lung function can exist even in asymptomatic 
thalassemia patients [11]. The number of studies 
on the association between lung function and the 
minor cases of thalassemia are limited. In patients 
with other hemoglobinopathies (like sickle cell 
anemia), both obstructive and restrictive changes 
have been observed in previous studies [12]. The 
study of lung function in iron deficiency anemia is 
mostly limited to some predefined lung disorders 
like chronic obstructive lung disease [13]. 
The association between microcytic anemia 
and pulmonary function tests have not been 
thoroughly investigated. The previous resear-
ches have highlighted the possibility of this 
association. The aim of this study was to assess 
the pulmonary function of patients with micro-
cytic anemia and to compare the results with the 
outcomes of the normal population in the city of 
Bandar Abbas, Iran. 
Material and methods
The study was conducted from the first of 
June 2016 to the first of June 2017 (one year). 
The study population consisted of all the pa-
tients admitted to the occupational medicine 
center in one of the general hospitals of the city 
of Bandar Abbas (Shahid Mohammadi hospital). 
The city is situated in the southern part of Iran 
(27 degrees north and 56 degrees east), and it has 
a subtropical climate with a high prevalence of 
thalassemia [14].
The study subjects were mostly symptom-free 
persons who were referred for an occupational 
fitness assessment. All of the participants went 
through physical examination and the Persian 
version of the Epworth Sleepiness Scale (to rule 
out obstructive sleep apnea) was filled by all of 
them [15]. The exclusion criteria consisted of the 
following: cigarette smoking (present and past), 
inability to perform an acceptable and reprodu-
cible spirogram based on the American Thoracic 
Society/European Respiratory Society (ATS/ERS) 
guidelines [16], history of recent respiratory tract 
infection (e.g. common cold in the past month) 
and other diseases that could affect the results of 
the study (pulmonary disorders like asthma and 
chronic obstructive lung disease, chest surgery, 
morbid obesity, history of any type of lung fibro-
sis, collagen-vascular disorders, neuromuscular 
diseases, and systemic muscle diseases), pre-
gnancy, other known hemoglobinopathies (ex-
cept minor thalassemia), iron deficiency anemia 
requiring intravenous or oral treatment, having 
had very high occupational exposure to dust, fu-
mes, solvents or noxious gases in the workplace, 
and not giving consent to the study. 
The results of spirometry for all the patients 
were obtained by the same technician and the 
same device (Mir spirolab III) with BTPS (Body 
Temperature and Pressure Saturated) correction. 
The tests were performed between 8:00 a.m. and 
12:00 noon. None of the subjects had hypoxemia 
before the maneuvers (determined by the pulse-
-oximetry accessory of the device). For about 42% 
of the subjects (939 subjects), maximum volun-
tary volume (MVV) was also obtained. Basing on 
the ATS/ERS criteria, forced expiratory volume or 
forced vital capacity (FVC) is defined as “maximal 
volume of air exhaled with maximally forced ef-
fort from a maximal inspiration, performed with 
a maximally forced expiratory effort”. Forced 
expiratory volume in the first second (FEV1) is 
defined as “maximal volume of air exhaled in the 
first second of a forced expiration from a position 
of full inspiration” [16]. The forced expiratory 
flow between 25% and 75% of the FVC is designa-
ted as FEF25-75 in this article. The ratio of FEV1 
to FVC has also been included in the analysis. 
The reference value equations were derived from 
the Global Lung Initiative (GLI-2012) [17], i.e.its 
excel sheet calculator [18].
For assessment of microcytic anemia, hemo-
globin levels less than 13.5 g/dl for men and less 
than 12.0 for women were considered anemic, and 
MCVs less than 80 fL were considered microcy-
tic. The Mentzer index was also used because it 
incorporates both MVC and red blood cell (RBC) 
count [19]. All the lab results were gathered from 
a single laboratory (belonging to the same general 
hospital) with the same technique throughout 
the study.
For every occupational health workup, phy-
sical and chemical exposures in the workplace 
are assessed by occupational hygienists and are 
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the part of occupational hazards. Because of the 
possible work-related reduction in the lung func-
tion, the exposures which had the possibility to 
deteriorate lung function (including exposure to 
dust, fumes, solvents, and noxious gases) were 
gathered as a variable called “exposures”. The 
variable was used in the analysis to adjust for 
the level of possible spirometric parameter dete-
rioration attributable to the subjects’ occupation.
Basing on the anemia type, the subjects were 
categorized into 3 main groups. One of them were 
normal persons with neither anemia nor microcy-
tosis. The second group consisted of patients with 
both anemia and microcytosis. The third group inc-
luded subjects with either anemia or microcytosis. 
The data were analyzed using SPSS version 
16 (SPSS Inc. Released 2007. SPSS for Windows, 
Version 16.0. Chicago, SPSS Inc.). Linear regres-
sion was applied to determine the relationship 
between the variables, and a p-value < 0.05 was 
considered statistically significant. Informed 
consent was obtained from all individual parti-
cipants included in the study, and the study was 
approved by the ethics committee of Hormozgan 
University of Medical Sciences.
Results
A total of 2,548 subjects participated in our 
cross-sectional study and 349 were excluded due 
to smoking, previous lung or other organ system 
disorders (mostly asthma), using treatment for 
iron deficiency, or inability to perform an ac-
ceptable maneuver. At last 2,199 subjects were 
included in the analysis. There were 1,903 men 
(86.5%) and 296 women (13.5%). 335 subjects 
(15.2%) had microcytic anemia, 1,686 subjects 
(76.7%) had neither anemia nor microcytosis, and 
178 subjects (8.1%) had either anemia or micro-
cytosis. Table 1 shows the demographic data and 
spirometric percentage values and hematologic 
indices in the sample population. 
For comparing the spirometric parameters 
between the subject groups, first, the patients 
Table 1. Demographic data and spirometric and lab data in four subcategories of the subjects
Subjects with either ane-
mia or microcytosis
Microcytic anemia 
subjects
Normal subjects
Demographic data
Total	number 178	(8.1%) 335	(15.2%) 1686	(76.7%)
Age	 34.23	±	0.66 34.04	±	0.46 33.75	±	0.19
Sex	(percentage	of	males) 56.7% 74.3% 92.1%
Weight	(kg) 66.31	±	0.96 68.58	±	0.75 75.64	±	0.35
Height	(cm) 169.4 169.5	±	0.44 172.8
Subjects	with	exposure	(Percent) 38.2% 51.3% 55.8%
Spirometric	data
FEV1	percentage*	 85.96	±	0.88 84.53	±	0.59 85.83	±	0.268
FEV1	Z	score* –1.13	±	0.07 –1.24	±	0.04 –1.14	±	0.02
FVC	percentage* 85.86	±	0.84 84.64	±	0.59 86.23	±	0.27
FVC	Z	score* –1.15	±	0.06 –1.15	±	0.06 –1.13	±	0.02
FEV1/FVC	Z	score* 0.01	±	0.06 0.01	±	0.05 –0.03	±	0.02
FEF	25–75	Z	score* –0.55	±	0.06 –0.58	±	0.04 –0.54	±	0.02
MVV	percentage** 81.95	±	1.82 84.2	±	1.41 84.75	±	0.58
Laboratory	data
WBC	(103/µL) 6.22	±	0.14 6.34	±	0.19 6.52	±	0.04
RBC	(106/µL) 4.69	±	0.04 5.54	±	0.05 5.41	±	0.01
Hemoglobin	(g/dL) 12.47	±	0.06 12.23	±	0.09 14.98	±	0.02
MCV	(fL) 82.27	±	0.45 70.40	±	0.48 82.32	±	0.16
Platelet	count	(106/µL) 249.7	±	4.7 242.5	±	5.6 233.6	±	1.3
*Based	on	GLI-2012	equations;	**	MVV	was	performed	on	only	939	subjects;	FEV1:	forced	expiratory	volume	in	the	first	second;	FVC:	forced	vital	capacity;	FEF	25–75:	
forced	expiratory	flow	between	25%	and	75%	of	expiration;	MVV:	maximum	voluntary	volume;	WBC:	white	blood	cell	count;	RBC:	red	blood	cell	count;	MCV:	mean	
corpuscular	volume
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Table 2.  ANOVA test for comparing the spirometric variables between those with microcytic anemia and normal  
population (those with either microcytosis or anemia are not included)
Microcytic anemia 
(n = 335)
Normal patients
(n = 1681)
p-value 
Mean Standard  
deviation
Mean Standard  
deviation
FEV1	percent 84.53 10.82 85.83 11.01 0.049
FEV1	Z	score –1.24 0.85 –1.14 0.88 0.053
FVC	percent 84.64 10.93 86.23 11.33 0.019
FVC	Z	score –1.25 0.89 –1.13 0.93 0.030
FEV1/FVC	Z	score 0.01 0.96 –0.03 0.92 0.370
FEF25–75	Z	score –0.58 0.89 –0.54 0.85 0.370
MVV	percent 84.24 15.56 84.75 15.94 0.746
FEV1:	forced	expiratory	volume	in	the	first	second;	FVC:	forced	vital	capacity;	FEF	25–75:	forced	expiratory	flow	between	25%	and	75%	of	expiration;	MVV:	maximum	
voluntary	volume
with microcytic anemia were compared to the 
normal subjects. For spirometric parameters, we 
used the GLI-2012 reference values for both per-
centages and Z scores. These values are adjusted 
for stature (height), age, sex, and ethnicity. Table 
2 shows that there are statistically significant dif-
ferences between FVC percentages and Z scores 
between the groups, and there are lower values 
in the subjects with microcytic anemia. There is 
also a reduction in FEV1 in the individuals with 
microcytic anemia, which has borderline signi-
ficance (the percentage is statistically significant 
but the Z score is not). 
In Table 3, the correlations between various 
hematological indices and spirometric parameters 
in the whole sample population are shown. The 
connections are not strong, but the correlation 
of some hematologic indices (RBC, MCV, and the 
Mentzer index) with FEV1 and FVC is statistically 
significant. The relationship of FEV1 and FVC 
with RBC is negative, but the correlation with 
MCV and the Mentzer index is positive.
Table 3. Correlation between spirometric indices and Hematologic indices
WBC RBC Hemoglobin MCV Mentzer Index Platelet count
FEV1	percent –0.028 –0.064** 0.014 0.057** 0.065** –0.029
FEV1	Z	score –0.023 –0.065** 0.015 0.060** 0.067** –0.029
FVC	percent –0.013 –0.070** 0.030 0.074** 0.077** –0.047*
FVC	Z	score –0.008 –0.076** 0.024 0.076** 0.082** –0.044*
FEV1/FVC	Z	score –0.034 0.012 –0.035 –0.034 –0.025 0.034
FEF25–75	Z	score –0.014 0.002 0.014 –0.003 –0.006 0.002
MVV	percent 0.011 0.050 0.082* 0.008 –0.028 0.004
*	Significant	at	0.05	level	
**	Significant	at	0.01	level
Because the GLI-2012 reference equations au-
tomatically adjust for height, sex, age, and ethnicity, 
there is no need for adjustment of these parameters. 
Since the subjects of the study were derived from 
an occupational clinic and because occupational 
exposures can influence the spirometric values, the 
exposures between the two groups were adjusted 
using linear regression. Table 4 shows the regression 
model with previously significant variables. As an 
example it can be adduced that a 20 units increase 
in MCV (e.g. from 65 to 85) predicts almost a 1.5 
percent increase in FVC in the sample population.
Each standardized coefficient is from a dif-
ferent model (e.g. combined effects of exposure 
and MCV on prediction of FVC percent)
Discussion and conclusion 
This study shows that there is an association 
between the spirometric parameters (FEV1 and 
FVC) and microcytic anemia. This correlation is 
positive for MCV and negative for RBC.
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Table 4.  Linear regression model for assessment of the increase in hematologic indices and spirometric values in all 
the subjects (normal, microcytosis or anemia and microcytic anemia) adjusted for exposure to dust, fumes, 
solvents, and noxious gases
Mentzer index MCV RBC
Standardized  
coefficient (Beta) 
p-value Standardized  
coefficient (Beta)
p-value Standardized  
coefficient (Beta)
p-value
FEV1	percent 0.065 0.002 0.057 0.008 –0.064 0.003
FEV1	Z	score 0.067 0.002 0.060 0.005 –0.066 0.002
FVC	percent 0.076 0.001 0.074 0.001 –0.070 0.001
FVC	Z	score 0.082 0.001 0.076 0.001 –0.076 0.001
There has been evidence that restrictive spi-
rometric pattern is prevalent in patients with ma-
jor thalassemia [9, 11, 20], and this study shows 
that there is a significant reduction in FVC in the 
patients with microcytic anemia. There are other 
researches that demonstrate a possible decrease 
in FEV1 in beta-thalassemia [10], and this study 
found that there is a reduction in this parameter 
in microcytic anemia with borderline statistical 
significance. Iron deficiency anemia has been 
shown to be associated with chronic obstructive 
lung disease [13, 21], but the studies on its effect 
on spirometric parameter values (not diseases) are 
scarce. The possible cause of these observations 
can be the reduced function of muscles due to 
iron deficiency anemia which has been shown 
to have an effect on the muscular function [22]. 
In most of the previously mentioned studies, the 
numbers of patients are low, which is logical 
because of the lower prevalence of major tha-
lassemia and the fact that the study subjects are 
usually children. These studies also used the 
cut-points in the spirometric values to diagnose 
possible restrictive or obstructive patterns. In 
our study, the quantitative values of spirometric 
parameters were used. 
In this study, the mechanism of the reduction 
in spirometric values due to microcytic anemia 
has not been evaluated. There are some possible 
causes. Mild hypoxia that can reduce the function 
of respiratory muscles can explain the reduction 
in FVC and to some extent the reduction in FEV1. 
Even though the results of pulse oximetry of the 
subjects were normal, it should be remembered 
that pulse oximetry alone cannot determine the 
amount of hypoxia (considering the Hemoglobin 
Bonn as an example) [23]. We did not include the 
subjects with clinical hypoxia, but there is a pos-
sibility that subclinical hypoxia can be associated 
with this reduction. For assessment of hypoxia, 
arterial blood gas is suggested. Another possible 
cause is pulmonary arterial hypertension which 
can reduce FEV1 and FVC in the patients [24]. 
There is also the possibility that there is a causal 
factor that causes both reduction in spirometric 
parameters and also microcytosis and anemia, 
and it needs to be determined. 
There are limitations to our study. Because 
the sample was selected from yearly occupational 
checkups, there were fewer female subjects than 
male subjects. In this study, the differentiation 
between the causes of the types of microcytic 
anemia was not determined. To establish the 
etiology of this reduction in spirometric values, 
further studies are recommended. There are other 
factors that influence lung function. The major 
concern in our study was the exposure to work 
hazards. These hazards were not quantitatively 
analyzed, and the binary definition of having 
the exposure and not having the exposure was 
used to exclude the possible confounder effect. 
This can be improved in future studies. When 
the amount of exposures is above a particular 
limit, the employer is needed to perform certain 
actions. Those subjects who had this amount of 
exposure were not included in the study. Only oc-
cupational exposures were available for the study 
and recreational exposures to hazards were not 
assessed. Yet, there are no obvious reasons that 
these recreational hazards are significantly dif-
ferent among the groups. Because it was a cross-
sectional study, only the association between the 
variables could be assessed, and the causality 
could not be determined. 
The subjects that attended our clinic were 
mostly healthy adults that demanded a yearly 
checkup required by the occupational law in Iran. 
The rate of the disease (especially lung disease) 
was minimal. Therefore, it was possible to deter-
mine the effects of microcytic anemia with the 
spirometric parameters without the confounding 
effects of other disorders. In this study, only the 
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association between microcytic anemia and the 
reduced spirometric values was assessed. Further 
studies are suggested to assess the possible me-
chanisms of this reduction. 
It can be concluded that microcytic anemia 
may reduce some spirometric parameters (mostly 
FVC and to a  lesser degree FEV1). Even though 
these changes are small, adjusting for these redu-
ced values can help prevent the overestimation 
of lung disorders, mostly in the borderline cases. 
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